Australia flagARTG 266182

Cryogenic spray, cutaneous

ARTG ID: 266182 · Perrigo Australia Pty Ltd · Omega Pharma International NV · Class IIa · Started December 16, 2015

Good Name: Perrigo Australia Pty Ltd - Cryogenic spray, cutaneous

Device classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration information
ARTG ID
266182
Start Date
December 16, 2015
Effective Date
December 16, 2015
Sponsor
Manufacturer
Country
Belgium
Address
Venecoweg 26, Nazareth, B-9810
Intended purpose

To indirectly freeze warts, plantar warts or verrucas by cooling an applicator which is applied to the skin causing the formation of a blister beneath the skin and the wart or verruca to fall off after a number of days whilst new skin is formed underneath the blister.

About this record

Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 266182 and sponsored by Perrigo Australia Pty Ltd, manufactured by Omega Pharma International NV in Belgium. The device registration started on December 16, 2015.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free DatabasePowered by Pure Global AITGA ARTG Official Data